Cargando…

DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives

Mutations in the protein DJ-1 cause autosomal recessive forms of Parkinson’s disease (PD) and oxidized DJ-1 is found in the brains of idiopathic PD individuals. While several functions have been ascribed to DJ-1 (most notably protection from oxidative stress), its contribution to PD pathogenesis is...

Descripción completa

Detalles Bibliográficos
Autores principales: Repici, Mariaelena, Giorgini, Flaviano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780414/
https://www.ncbi.nlm.nih.gov/pubmed/31484320
http://dx.doi.org/10.3390/jcm8091377
_version_ 1783457135022047232
author Repici, Mariaelena
Giorgini, Flaviano
author_facet Repici, Mariaelena
Giorgini, Flaviano
author_sort Repici, Mariaelena
collection PubMed
description Mutations in the protein DJ-1 cause autosomal recessive forms of Parkinson’s disease (PD) and oxidized DJ-1 is found in the brains of idiopathic PD individuals. While several functions have been ascribed to DJ-1 (most notably protection from oxidative stress), its contribution to PD pathogenesis is not yet clear. Here we provide an overview of the clinical research to date on DJ-1 and the current state of knowledge regarding DJ-1 characterization in the human brain. The relevance of DJ-1 as a PD biomarker is also discussed, as are studies exploring DJ-1 as a possible therapeutic target for PD and neurodegeneration.
format Online
Article
Text
id pubmed-6780414
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67804142019-10-30 DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives Repici, Mariaelena Giorgini, Flaviano J Clin Med Review Mutations in the protein DJ-1 cause autosomal recessive forms of Parkinson’s disease (PD) and oxidized DJ-1 is found in the brains of idiopathic PD individuals. While several functions have been ascribed to DJ-1 (most notably protection from oxidative stress), its contribution to PD pathogenesis is not yet clear. Here we provide an overview of the clinical research to date on DJ-1 and the current state of knowledge regarding DJ-1 characterization in the human brain. The relevance of DJ-1 as a PD biomarker is also discussed, as are studies exploring DJ-1 as a possible therapeutic target for PD and neurodegeneration. MDPI 2019-09-03 /pmc/articles/PMC6780414/ /pubmed/31484320 http://dx.doi.org/10.3390/jcm8091377 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Repici, Mariaelena
Giorgini, Flaviano
DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
title DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
title_full DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
title_fullStr DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
title_full_unstemmed DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
title_short DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
title_sort dj-1 in parkinson’s disease: clinical insights and therapeutic perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780414/
https://www.ncbi.nlm.nih.gov/pubmed/31484320
http://dx.doi.org/10.3390/jcm8091377
work_keys_str_mv AT repicimariaelena dj1inparkinsonsdiseaseclinicalinsightsandtherapeuticperspectives
AT giorginiflaviano dj1inparkinsonsdiseaseclinicalinsightsandtherapeuticperspectives